TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype

Breast Cancer Research and Treatment

Volumn 113, Issue 2, 2009, Pages 217-230

  Rahman, Monzur ^a   Davis, Sean R ^a   Pumphrey, Janet G ^a   Bao, Jing ^a   Nau, Marion M ^a   Meltzer, Paul S ^a   Lipkowitz, Stanley ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Basal breast cancer; TRAIL; Triple negative breast cancer

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; DEATH RECEPTOR 4; DEATH RECEPTOR 5; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN TYROSINE KINASE INHIBITOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; LIGAND BINDING; MESENCHYME CELL; MICROARRAY ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; RNA INTERFERENCE;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; EPITHELIUM; FEMALE; GENES, ERBB-2; HUMANS; MESODERM; NEOPLASM PROTEINS; PHENOTYPE; PROTEIN KINASE INHIBITORS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECOMBINANT FUSION PROTEINS; RNA INTERFERENCE; TYRPHOSTINS;

EID: 58149237789     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-9924-5     Document Type: Article

References (36)

1. MM Keane SA Ettenberg MM Nau EK Russell S Lipkowitz 1999 Chemotherapy augments TRAIL-induced apoptosis in breast cell lines Cancer Res 59 3 734 741
2. A Chinnaiyan U Prasad S Shankar DA Hamstra M Shanaiah TL Chenevert BD Ross A Rehemtulla 2000 Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy Proc Natl Acad Sci USA 97 4 1754 1759
3. H Walczak RE Miller K Ariail 1999 Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo Nat Med 5 2 157 163
4. JD Brenton LA Carey AA Ahmed C Caldas 2005 Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol 23 29 7350 7360
5. M Cuello SA Ettenberg AS Clark MM Keane RH Posner MM Nau PA Dennis S Lipkowitz 2001 Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2 Cancer Res 61 12 4892 4900
6. RM Neve K Chin J Fridlyand 2006 A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes Cancer Cell 10 6 515 527
7. RC Gentleman VJ Carey DM Bates 2004 Bioconductor: open software development for computational biology and bioinformatics Genome Biol 5 10 R80
8. Smyth GK (2005) Limma: linear models for microarray data. In: Gentleman RC et al (eds) Bioinformatics and computational biology solutions using R and Bioconductor. Springer, New York, pp 397-420
9. Y Benjamini Y Hochberg 1995 Controlling the false discovery rate: a pratical and powerful approach to multiple testing J R Stat Soc 57 289 300
10. SP Ethier 1996 Human breast cancer cell lines as models of growth regulation and disease progression J Mammary Gland Biol Neoplasia 1 1 111 121
11. L Flanagan K Van Weelden C Ammerman SP Ethier J Welsh 1999 SUM-159PT cells: a novel estrogen independent human breast cancer model system Breast Cancer Res Treat 58 3 193 204
12. A Ashkenazi 2002 Targeting death and decoy receptors of the tumour-necrosis factor superfamily Nat Rev Cancer 2 6 420 430
13. Weinberg RA (2007) The biology of cancer. Garland Science, New York
14. E Charafe-Jauffret F Monville F Bertucci 2007 Moesin expression is a marker of basal breast carcinomas Int J Cancer 121 8 1779 1785
15. RS Finn J Dering C Ginther CA Wilson P Glaspy N Tchekmedyian DJ Slamon 2007 Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple- negative" breast cancer cell lines growing in vitro Breast Cancer Res Treat 105 3 319 326
16. E Korsching J Packeisen K Agelopoulos 2002 Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis Lab Invest 82 11 1525 1533
17. CA Livasy G Karaca R Nanda MS Tretiakova OI Olopade DT Moore CM Perou 2006 Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma Mod Pathol 19 2 264 271
18. EM Gibson ES Henson N Haney J Villanueva SB Gibson 2002 Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release Cancer Res 62 2 488 496
19. S Gibson S Tu R Oyer SM Anderson GL Johnson 1999 Epidermal growth factor protects epithelial cells against Fas-induced apoptosis. Requirement for Akt activation J Biol Chem 274 25 17612 17618
20. SY Park DW Seol 2002 Regulation of Akt by EGF-R inhibitors, a possible mechanism of EGF-R inhibitor-enhanced TRAIL-induced apoptosis Biochem Biophys Res Commun 295 2 515 518
21. A Levitzki A Gazit 1995 Tyrosine kinase inhibition: an approach to drug development Science 267 5205 1782 1788
22. J Filmus MN Pollak R Cailleau RN Buick 1985 MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF Biochem Biophys Res Commun 128 2 898 905
23. J Lebeau G Goubin 1987 Amplification of the epidermal growth factor receptor gene in the BT20 breast carcinoma cell line Int J Cancer 40 2 189 191
24. E Charafe-Jauffret C Ginestier F Monville 2006 Gene expression profiling of breast cell lines identifies potential new basal markers Oncogene 25 15 2273 2284
25. T Sorlie CM Perou R Tibshirani 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 19 10869 10874
26. S Umemura S Takekoshi Y Suzuki Y Saitoh Y Tokuda RY Osamura 2005 Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression Oncol Rep 14 2 337 343
27. B Willipinski-Stapelfeldt S Riethdorf V Assmann U Woelfle T Rau G Sauter J Heukeshoven K Pantel 2005 Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells Clin Cancer Res 11 22 8006 8014
28. SC Hughes RG Fehon 2007 Understanding ERM proteins - the awesome power of genetics finally brought to bear Curr Opin Cell Biol 19 1 51 56
29. KW Wagner EA Punnoose T Januario 2007 Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL Nat Med 13 9 1070 1077
30. F Meric WP Lee A Sahin H Zhang HJ Kung MC Hung 2002 Expression profile of tyrosine kinases in breast cancer Clin Cancer Res 8 2 361 367
31. SJ Holland MJ Powell C Franci 2005 Multiple roles for the receptor tyrosine kinase axl in tumor formation Cancer Res 65 20 9294 9303
32. V Evtimova R Zeillinger UH Weidle 2003 Identification of genes associated with the invasive status of human mammary carcinoma cell lines by transcriptional profiling Tumour Biol 24 4 189 198
33. M Shipitsin LL Campbell P Argani 2007 Molecular definition of breast tumor heterogeneity Cancer Cell 11 3 259 273
34. RF Kelley K Totpal SH Lindstrom M Mathieu K Billeci L Deforge R Pai SG Hymowitz A Ashkenazi 2005 Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling J Biol Chem 280 3 2205 2212
35. M MacFarlane SL Kohlhaas MJ Sutcliffe MJ Dyer GM Cohen 2005 TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies Cancer Res 65 24 11265 11270
36. AM vander Sloot V Tur E Szegezdi MM Mullally RH Cool A Samali L Serrano WJ Quax 2006 Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor Proc Natl Acad Sci USA 103 23 8634 8639